These mechanisms include oxidative stress, endoplasmic reticulum stress, inflammation, tyrosine kinases, advanced glycation end products, poly(ADP-ribose) polymerase 1, impaired nitric oxide (NO) production, insulin signaling, hyperglycemia, and hyperlipidemia (7, 9, 25–29). The gene discussed is INS; the disease is hyperlipidemia.